Fructus choerospondiatis : A comprehensive review of its traditional uses, chemical composition, pharmacological activities, and clinical studies
Copyright © 2024 Elsevier B.V. All rights reserved..
ETHNOPHARMACOLOGICAL RELEVANCE: Fructus Choerospondiatis is the dried and mature fruit of Choerospondias axillaris (Roxb.) Burtt et Hill. It has been used for a long time in Tibetan and Mongolian medicine, first recorded in the ancient Tibetan medicine book "Medicine Diagnosis of the King of the Moon" in the early 8th century. Fructus Choerospondiatis shows multiple pharmacological activities, especially in treating cardiovascular diseases.
AIM OF THIS REVIEW: This paper reviews the progress in research on the botanical characteristics, traditional uses, chemical constituents, pharmacological activity, clinical studies, and quality control of Fructus Choerospondiatis. This review aims to summarize current research and provide a reference for further development and utilization of Fructus Choerospondiatis resources.
METHOD: The sources for this review include the Pharmacopeia of the People's Republic of China (2020), theses, and peer-reviewed papers (in both English and Chinese). Theses and papers were downloaded from electronic databases including Web of Science, PubMed, SciFinder, Scholar, Springer, and China National Knowledge Infrastructure.The search terms used were "Choerospondias axillaris", "C. axillaris", "Choerospondias axillaris (Roxb.) Burtt et Hill", "Fructus choerospondiatis", "Guangzao", "Lapsi", and "Lupsi".
RESULTS: Fructus Choerospondiatis contains polyphenols, organic acids, amino acids, fatty acids, polysaccharides, and other chemical components. These ingredients contribute to its diverse pharmacological activities such as antioxidant activity, protection against myocardial ischemia-reperfusion injury, anti-myocardial fibrosis, heart rhythm regulation, anti-tumor, liver protection, and immunity enhancement. It also affects the central nervous system, with the ability to repair damaged nerve cells.
CONCLUSION: Fructus Choerospondiatis, with its various chemical compositions and pharmacological activities, is a promising medicinal resource. However, it remains under-researched, particularly in pharmacodynamic material basis and quality control. These areas require further exploration by researchers in the future.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:323 |
---|---|
Enthalten in: |
Journal of ethnopharmacology - 323(2024) vom: 06. Jan., Seite 117696 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rong, Weiwei [VerfasserIn] |
---|
Links: |
---|
Themen: |
Botany |
---|
Anmerkungen: |
Date Completed 29.01.2024 Date Revised 29.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jep.2023.117696 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36662086X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36662086X | ||
003 | DE-627 | ||
005 | 20240129232047.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240108s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jep.2023.117696 |2 doi | |
028 | 5 | 2 | |a pubmed24n1274.xml |
035 | |a (DE-627)NLM36662086X | ||
035 | |a (NLM)38171468 | ||
035 | |a (PII)S0378-8741(23)01566-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rong, Weiwei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fructus choerospondiatis |b A comprehensive review of its traditional uses, chemical composition, pharmacological activities, and clinical studies |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.01.2024 | ||
500 | |a Date Revised 29.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
520 | |a ETHNOPHARMACOLOGICAL RELEVANCE: Fructus Choerospondiatis is the dried and mature fruit of Choerospondias axillaris (Roxb.) Burtt et Hill. It has been used for a long time in Tibetan and Mongolian medicine, first recorded in the ancient Tibetan medicine book "Medicine Diagnosis of the King of the Moon" in the early 8th century. Fructus Choerospondiatis shows multiple pharmacological activities, especially in treating cardiovascular diseases | ||
520 | |a AIM OF THIS REVIEW: This paper reviews the progress in research on the botanical characteristics, traditional uses, chemical constituents, pharmacological activity, clinical studies, and quality control of Fructus Choerospondiatis. This review aims to summarize current research and provide a reference for further development and utilization of Fructus Choerospondiatis resources | ||
520 | |a METHOD: The sources for this review include the Pharmacopeia of the People's Republic of China (2020), theses, and peer-reviewed papers (in both English and Chinese). Theses and papers were downloaded from electronic databases including Web of Science, PubMed, SciFinder, Scholar, Springer, and China National Knowledge Infrastructure.The search terms used were "Choerospondias axillaris", "C. axillaris", "Choerospondias axillaris (Roxb.) Burtt et Hill", "Fructus choerospondiatis", "Guangzao", "Lapsi", and "Lupsi" | ||
520 | |a RESULTS: Fructus Choerospondiatis contains polyphenols, organic acids, amino acids, fatty acids, polysaccharides, and other chemical components. These ingredients contribute to its diverse pharmacological activities such as antioxidant activity, protection against myocardial ischemia-reperfusion injury, anti-myocardial fibrosis, heart rhythm regulation, anti-tumor, liver protection, and immunity enhancement. It also affects the central nervous system, with the ability to repair damaged nerve cells | ||
520 | |a CONCLUSION: Fructus Choerospondiatis, with its various chemical compositions and pharmacological activities, is a promising medicinal resource. However, it remains under-researched, particularly in pharmacodynamic material basis and quality control. These areas require further exploration by researchers in the future | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Botany | |
650 | 4 | |a Clinical study | |
650 | 4 | |a Fructus choerospondiatis | |
650 | 4 | |a Pharmacology | |
650 | 4 | |a Quality control | |
650 | 7 | |a Phytochemicals |2 NLM | |
650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
700 | 1 | |a Shi, Qilin |e verfasserin |4 aut | |
700 | 1 | |a Yang, Yuru |e verfasserin |4 aut | |
700 | 1 | |a Su, Weiyi |e verfasserin |4 aut | |
700 | 1 | |a Li, Mingna |e verfasserin |4 aut | |
700 | 1 | |a Qin, Minni |e verfasserin |4 aut | |
700 | 1 | |a Bai, Shuang |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Qing |e verfasserin |4 aut | |
700 | 1 | |a Wang, Andong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of ethnopharmacology |d 1980 |g 323(2024) vom: 06. Jan., Seite 117696 |w (DE-627)NLM00095196X |x 1872-7573 |7 nnns |
773 | 1 | 8 | |g volume:323 |g year:2024 |g day:06 |g month:01 |g pages:117696 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jep.2023.117696 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 323 |j 2024 |b 06 |c 01 |h 117696 |